IPCALAB - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 4.0
| Stock Code | IPCALAB | Market Cap | 39,963 Cr. | Current Price | 1,573 ₹ | High / Low | 1,679 ₹ |
| Stock P/E | 39.8 | Book Value | 292 ₹ | Dividend Yield | 0.25 % | ROCE | 17.3 % |
| ROE | 12.4 % | Face Value | 1.00 ₹ | DMA 50 | 1,542 ₹ | DMA 200 | 1,471 ₹ |
| Chg in FII Hold | 0.01 % | Chg in DII Hold | 0.14 % | PAT Qtr | 303 Cr. | PAT Prev Qtr | 305 Cr. |
| RSI | 51.5 | MACD | 21.0 | Volume | 78,026 | Avg Vol 1Wk | 1,60,046 |
| Low price | 1,252 ₹ | High price | 1,679 ₹ | PEG Ratio | -31.1 | Debt to equity | 0.11 |
| 52w Index | 75.2 % | Qtr Profit Var | 13.4 % | EPS | 31.7 ₹ | Industry PE | 31.6 |
📊 Chart & Trend Analysis:
IPCALAB is trading above both its 50 DMA (₹1,542) and 200 DMA (₹1,471), confirming bullish momentum. RSI at 51.5 indicates neutral-to-positive strength. MACD at 21.0 shows a strong positive crossover. Bollinger Bands place price near the mid-to-upper range, with support around ₹1,542.
📈 Momentum Signals:
- Short-term momentum is positive, though volume (78K) is below weekly average (1.60L), showing weaker participation.
- Support zone: ₹1,540 – ₹1,555.
- Resistance zone: ₹1,620 – ₹1,640.
- Break above ₹1,640 could trigger a rally toward ₹1,679; failure to hold ₹1,540 may lead to consolidation.
🔎 Trend Status:
Currently trending upward with bullish undertones. Sustained buying above ₹1,600 will confirm continuation of the uptrend.
---
Positive
✔ Strong ROCE (17.3%) and ROE (12.4%).
✔ EPS at ₹31.7 supports valuation strength.
✔ Low debt-to-equity ratio (0.11) ensures financial stability.
✔ 52-week performance at +75.2% shows strong momentum.
Limitation
⚠ High P/E ratio (39.8) vs industry PE (31.6) indicates premium valuation.
⚠ PEG ratio at -31.1 suggests poor valuation relative to growth.
⚠ Dividend yield modest at 0.25%.
⚠ Volume participation remains weak compared to average.
Company Negative News
📉 Sequential PAT decline (₹305 Cr → ₹303 Cr).
📉 Valuation concerns due to high P/E and negative PEG.
Company Positive News
📢 Quarterly profit variance +13.4% shows earnings growth.
📢 Stable institutional holdings (FII +0.01%, DII +0.14%).
📢 Technical breakout above both DMA levels.
Industry
🌐 Industry PE at 31.6 vs IPCALAB’s 39.8 — premium valuation.
🌐 Pharma sector supported by long-term demand but facing margin pressures.
Conclusion
IPCALAB is trending upward with bullish signals from DMA, RSI, and MACD. Entry near ₹1,540–₹1,555 offers favorable risk-reward, with exit targets around ₹1,620–₹1,640. Fundamentals remain stable, though valuation is stretched. Traders can ride momentum with strict stop-loss discipline, while long-term investors should be cautious of overvaluation.
Would you like me to extend this into a swing trade outlook with medium-term layered targets, or refine it into an intraday momentum strategy for tighter entry/exit levels?